What is PelVIP?
Operating out of Oak Lawn, Illinois, PelVIP—formerly known as Pulmonary Exchange Ltd—functions as a critical player in the medical devices industry. With a workforce of 51-100 professionals and annual revenues ranging between $10M and $25M, the organization has established a robust footprint in respiratory care technology. By focusing on high-precision medical hardware, the company maintains a specialized market position that bridges the gap between clinical research and patient-centric therapeutic delivery. Their current lifecycle stage, characterized by late-stage financing, suggests a transition from initial product-market fit to aggressive expansion and infrastructure optimization.
How much funding has PelVIP raised?
PelVIP has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in PelVIP
PPP
Public-Private Partnership
What's next for PelVIP?
With the recent influx of capital, PelVIP is positioned to accelerate its research and development initiatives while potentially expanding its commercial reach. The strategic allocation of these funds will likely prioritize the enhancement of existing medical device portfolios and the scaling of manufacturing processes to meet rising demand. As the company navigates this growth phase, stakeholders will be monitoring its ability to leverage this financing to capture additional market share and solidify its reputation as a leader in pulmonary exchange technology. Future milestones will likely involve regulatory advancements and the potential for broader clinical adoption of their proprietary hardware solutions.
See full PelVIP company page
